FIELD: organic chemistry, medicine. SUBSTANCE: invention relates to novel drugs used for treatment of patients with obsessive-compulsive disorders. As an active substance of drug invention proposes compound of the formula: where m = 1 or 2; R means halogen atom, lower alkyl, lower alkoxy-group, aryl-(lower alkoxy-group), hydroxyl, nitro-group, amino-(lower alkyl)-amino-group or di-(lower alkyl)-amino-group; R1 means hydrogen atom or lower alkyl; R2 means hydrogen atom or lower alkyl and R3 means hydrogen, halogen atom or lower alkyl, or its pharmaceutically acceptable salt of acid addition. Effect of the new agent is caused by inhibition of serotonin reuptake. EFFECT: valuable medicinal properties. 11 cl, 45 ex
Authors
Dates
2001-04-10—Published
1994-07-18—Filed